January/February 2025

• NPAC Submitted an extensive public comment on the Center for Disease Control and Prevention’s proposal to evaluate the impact of its 2022 Prescribing Guidelines.

• NPAC joined the Medicaid Day of Action and continues with advocacy efforts to protect the health safety net.

• NPAC’s Executive Director, Dr. Tamara Baker, and Dr. Monica Mallampalli participated in the NIH Interagency Pain Research Coordinating Committee meetings.

• NPAC’s Executive Director participated in a governing board meeting for the NIH PURPOSE program.

• NPAC’s President and Executive Director planned a 3-hour Advocacy Training Session for scientists and clinicians for the upcoming Scientific Meeting of the US Association for the Study of Pain (USASP).

• NPAC will also offer Symposia at the upcoming scientific meetings of the European Pain Federation (EFIC) (on data harmonization) and the Canadian Pain Society (CPS) (one on pain and human rights, and one on building resilience in pain and substance use disorders).

• NPAC Advisor Mara Baer was interviewed regarding chronic pain for the report on Aging by the Alliance for Health Policy.

• NPAC’s Executive Director spoke with Alyssa Quart for Time magazine about Health Insecurity.

• NPAC advisor Dr. Stefan Kertesz was featured in an article about opioid prescribing.

• NPAC’s Executive Director co-authored a Lessons Learned paper for Pain Medicine on the INTEGRATE-Pain global Delphi study to develop core outcome measures for acute, chronic, acute to chronic translation, and episodic pain.